Allergy Therapeutics hands retained brief to Consilium
Speciality pharma company Allergy Therapeutics has hired Consilium Strategic Communications as its international financial PR and investor relations adviser.
The London-listed pharma company focuses on the treatment of allergic disorders including immunotherapy vaccines.
Mary-Jane Elliott, Chris Gardner, Ivar Milligan, Matthew Neal and Laura Thornton make up the Consilium team advising the client.
Elliott, managing partner at Consilium, said: “We are delighted to be advising Allergy Therapeutics – at a time when it is on a steep growth trajectory due to a strong portfolio of marketed products and M&A. We look forward to accompanying it on its journey as it paves the way to the US market and further international growth.”
Manuel Llobet, Allergy Therapeutics’ CEO, added: “Consilium is Europe’s only specialist healthcare financial communications firm. The team’s expertise and knowledge of the sector is unrivalled and it has already demonstrated this through high quality advice, proactivity and professionalism. We look forward to using its resources to step up international stakeholder activities in order to raise our profile, particularly in the US, in front of both the investor and allergist communities.”